Construction of VRC Addition Begins

Construction began recently on the NIAID Vaccine Research Center’s Bldg. 40A.

Photo: Chia-Chi Charlie Chang

The new facility will be 158,000 square feet with 5 working floors and a ground level.

Construction has commenced on the NIAID Vaccine Research Center’s Bldg. 40A, a tower adjacent to the current Bldg. 40 at the intersection of South Drive and Convent Drive on NIH’s main campus. For the latest  information on navigating around construction, see https://traffic.nih.gov/Pages/default.aspx.

The new facility will be 158,000 square feet with 5 working floors and a ground level. Floors 2 to 5 will have large and small meeting rooms, laboratory space, tissue culture rooms and designated equipment rooms. Staff will be able to walk between the two buildings on each level and collaborate with each other with ease. 

The new space will support VRC’s mission to facilitate development of effective vaccines for human diseases. The expansion also will create new opportunities for trainees and early-career investigators to further contribute to a broad array of research programs.